Search
Menu
Home
HTB
2002
September
HTB
September 2002
Contents
On the web
‘Natural’ resistance to HIV: is the evidence good enough to design an effective vaccine?
Insights into HIV-specific CD4+ T cell immunity
Cytomegalovirus: update
The switching spiral: a triumph of hope over benefit?
Peripheral neuropathy
The push for once-daily HAART: a call for caution
Enhancing adherence to antiretrovirals: strategies and regimens
High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia
HAART and prevention of HIV transmission
PDFs
Volume 3 Number 7 August/September 2002 PDF
Post navigation
Newer articles
HTB RSS
Early access
Doravirine studies at Glasgow 2022
6 February 2023
Pipeline studies at Glasgow 2022
6 February 2023
Long-acting cabotegravir/rilpivirine: Adverse events, implementation and PROMs
6 February 2023
Lenacapavir approved in the US for multidrug resistant HIV
6 February 2023
All early access reports
Current issues
February 2023
January 2023
December 2022
Back issues
Special report
Latest statistics on HIV in the UK: data for 2021
1 December 2022
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage